ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2017 | OSHA | $6,518 |
DEPUY SYNTHES PRODUCTS, LLC | Johnson & Johnson | workplace safety or health violation | 2018 | OSHA | $5,654 |
ALCAMI CORPORATION | Alcami | workplace safety or health violation | 2018 | OSHA | $6,652 |
JOHNSON & JOHNSON CONSUMER, INC. | Johnson & Johnson | workplace safety or health violation | 2018 | OSHA | $7,853 |
SIGMA-ALDRICH | Merck KGaA (EMD) | workplace safety or health violation | 2018 | OSHA | $23,632 |
CAMBREX CHARLES CITY, INC. | Cambrex | workplace safety or health violation | 2018 | OSHA | $18,000 |
DEPUY SYNTHES | Johnson & Johnson | workplace safety or health violation | 2019 | OSHA | $5,000 |
TARO PHARMACEUTICALS USA, INC. | Sun Pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $18,565 |
CSL PLASMA | CSL Limited | workplace safety or health violation | 2019 | OSHA | $15,422 |
WOCKHARDT USA MORTON GROVE DBA MORTON GROVE PHARMACEUTICALS, INC. | Wockhardt Limited | workplace safety or health violation | 2019 | OSHA | $7,900 |
PHARMAVITE LLC | Otsuka Pharmaceutical | workplace safety or health violation | 2019 | OSHA | $5,775 |
GENERAL NUTRITION CORPORATION | Harbin Pharmaceutical Group | workplace safety or health violation | 2019 | OSHA | $7,674 |
ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2020 | OSHA | $9,832 |
HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
AKORN OPERATING COMPANY, LLC | Akorn Inc. | workplace safety or health violation | 2020 | OSHA | $13,653 |
EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | workplace safety or health violation | 2021 | OSHA | $10,240 |
PBM NUTRITIONALS LLC | Perrigo | workplace safety or health violation | 2021 | OSHA | $14,502 |
ROCHE MOLECULAR SYSTEMS, INC. | Roche | workplace safety or health violation | 2021 | OSHA | $9,300 |
MYLAN TECHNOLOGIES, INC. | Viatris | workplace safety or health violation | 2021 | OSHA | $13,653 |
GNC HOLDINGS LLC | Harbin Pharmaceutical Group | workplace safety or health violation | 2022 | OSHA | $6,720 |
DEPUY SYNTHES PRODUCTS, INC. | Johnson & Johnson | workplace safety or health violation | 2022 | OSHA | $7,044 |
MODERNA, INC | Moderna Inc. | workplace safety or health violation | 2022 | OSHA | $6,000 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $6,250 |
AMNEAL PHARMACEUTICALS, LLC | Amneal Pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $8,439 |
ULTRAGENYX PHARMACEUTICAL | Ultragenyx Pharmaceutical | workplace safety or health violation | 2023 | OSHA | $12,054 |
GNC HOLDINGS INC. | Harbin Pharmaceutical Group | workplace safety or health violation | 2023 | OSHA | $17,858 |
IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | workplace safety or health violation | 2023 | OSHA | $32,245 |
VERSUM MATERIALS | Merck KGaA (EMD) | workplace safety or health violation | 2023 | OSHA | $8,438 |
PERRIGO COMPANY PLC | Perrigo | workplace safety or health violation | 2023 | OSHA | $12,600 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Dey Pharmaceuticals | Viatris | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Merck | Merck | drug or medical equipment safety violation | 2013 | PA-AG | $8,250,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2016 | PA-ENV | $6,943 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2003 | PA-ENV | $8,978 |
SANOFI PASTEUR | Sanofi | environmental violation | 2006 | PA-ENV | $28,620 |
SANOFI PASTEUR | Sanofi | environmental violation | 2007 | PA-ENV | $6,400 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2016 | PA-ENV | $14,906 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2014 | PA-ENV | $12,270 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2009 | PA-ENV | $15,720 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2007 | PA-ENV | $12,565 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2006 | PA-ENV | $5,033,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2006 | PA-ENV | $194,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2005 | PA-ENV | $7,950 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2000 | PA-ENV | $15,086 |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | environmental violation | 2016 | PA-ENV | $5,259 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Allergan Ltd. | AbbVie | off-label or unapproved promotion of medical products | 2022 | RI-AG | $7,500,000 |
PHIBRO-TECH, INC | Phibro Animal Health | hazardous waste violation | 2011 | SC-ENV | $15,000 |
PHIBRO-TECH | Phibro Animal Health | air pollution violation | 2004 | SC-ENV | $7,500 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Eli Lilly and Company | Eli Lilly | Foreign Corrupt Practices Act | 2012 | SEC | $29,398,734 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | SEC | $48,600,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Elan Corporation, plc | Perrigo | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Schering-Plough Corporation | Merck | Foreign Corrupt Practices Act | 2004 | SEC | $500,000 |
Schering-Plough Corporation | Merck | investor protection violation | 2003 | SEC | $1,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
GlaxoSmithKline plc | GlaxoSmithKline | kickbacks and bribery | 2016 | SEC | $20,000,000 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Allergan Inc. | AbbVie | investor protection violation | 2017 | SEC | $15,000,000 |
Galena Biopharma, Inc. | SELLAS Life Sciences Group | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
Alere Inc. | Abbott Laboratories | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |
Aegerion Pharmaceuticals | Amryt Pharma | investor protection violation | 2017 | SEC | $4,100,000 |
Cytrx Corporation | CytRx | investor protection violation | 2017 | SEC | $75,000 |
Sanofi | Sanofi | Foreign Corrupt Practices Act | 2018 | SEC | $25,200,000 |
Clovis Oncology Inc. | Clovis Oncology | investor protection violation | 2018 | SEC | $20,000,000 |
Mylan N.V. | Viatris | investor protection violation | 2019 | SEC | $30,000,000 |
Bausch Health | Bausch Health | accounting fraud or deficiencies | 2020 | SEC | $45,000,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2020 | SEC | $112,800,000 |
Amyris, Inc. | Amyris | investor protection violation | 2021 | SEC | $300,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2012 | TX-AG | $158,000,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Purdue Frederick Co. | Purdue Pharma | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Schering-Plough Corp. | Merck | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Lupin Pharmaceuticals, Inc. | Lupin Limited | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |